Charles Schwab · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Charles Schwab Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 1.8M | $659M | — |
| 2024Q2 | 2.0M | $768M | +16.5% |
| 2024Q3 | 2.1M | $773M | +0.7% |
| 2024Q4 | 2.1M | $693M | -10.3% |
| 2025Q1 | 2.2M | $852M | +22.8% |
| 2025Q2 | 2.3M | $807M | -5.2% |
| 2025Q3 | 4.6M | $1.6B | +96.1% |
| 2025Q4 | 2.5M | $855M | -46.0% |
| 2026Q1 | 2.5M | $865M | +1.2% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F